Mirae Asset Global Investments Co. Ltd. Boosts Stake in Linde PLC $LIN

Mirae Asset Global Investments Co. Ltd. grew its holdings in Linde PLC (NASDAQ:LIN) by 12.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 198,167 shares of the basic materials company’s stock after purchasing an additional 21,700 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Linde were worth $94,129,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Darwin Wealth Management LLC purchased a new position in Linde during the second quarter worth about $25,000. Marquette Asset Management LLC purchased a new stake in shares of Linde in the 3rd quarter valued at approximately $27,000. YANKCOM Partnership lifted its holdings in shares of Linde by 195.2% in the 3rd quarter. YANKCOM Partnership now owns 62 shares of the basic materials company’s stock worth $29,000 after acquiring an additional 41 shares during the last quarter. Albion Financial Group UT boosted its position in shares of Linde by 87.8% during the 3rd quarter. Albion Financial Group UT now owns 77 shares of the basic materials company’s stock worth $37,000 after purchasing an additional 36 shares during the period. Finally, Howard Hughes Medical Institute acquired a new stake in Linde in the 2nd quarter valued at approximately $48,000. 82.80% of the stock is owned by institutional investors and hedge funds.

Linde Stock Performance

Shares of LIN opened at $451.50 on Thursday. The company has a quick ratio of 0.69, a current ratio of 0.82 and a debt-to-equity ratio of 0.46. Linde PLC has a 52-week low of $387.78 and a 52-week high of $486.38. The stock has a 50 day moving average price of $424.00 and a 200 day moving average price of $447.95. The company has a market capitalization of $210.83 billion, a price-to-earnings ratio of 30.24, a price-to-earnings-growth ratio of 3.18 and a beta of 0.85.

Linde (NASDAQ:LIN) last issued its quarterly earnings data on Friday, October 31st. The basic materials company reported $4.21 earnings per share for the quarter, topping the consensus estimate of $4.18 by $0.03. The business had revenue of $8.62 billion during the quarter, compared to the consensus estimate of $8.62 billion. Linde had a net margin of 21.17% and a return on equity of 19.38%. The company’s revenue was up 2.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.94 EPS. Linde has set its FY 2025 guidance at 16.350-16.450 EPS and its Q4 2025 guidance at 4.100-4.200 EPS. Research analysts predict that Linde PLC will post 16.54 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have commented on LIN shares. UBS Group restated a “buy” rating on shares of Linde in a research note on Friday, December 12th. CICC Research began coverage on Linde in a research note on Wednesday, December 3rd. They set an “outperform” rating and a $510.00 target price on the stock. JPMorgan Chase & Co. dropped their target price on Linde from $475.00 to $455.00 and set an “overweight” rating for the company in a research report on Monday, November 3rd. Sanford C. Bernstein reiterated an “outperform” rating and set a $516.00 price target on shares of Linde in a research note on Monday, November 3rd. Finally, Citigroup increased their target price on shares of Linde from $520.00 to $540.00 and gave the stock a “buy” rating in a report on Wednesday, January 21st. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Linde has an average rating of “Buy” and an average price target of $501.75.

Linde Profile

Linde (NASDAQ: LIN) is a multinational industrial gases and engineering company that supplies gases, related technologies and services to a wide range of industries. The company traces its current form to the 2018 combination of Germany’s Linde AG and U.S.-based Praxair, creating one of the largest global providers of industrial, specialty and medical gases. Linde’s business model centers on production, processing and distribution of gases as well as the design and construction of the plants and equipment needed to produce them.

Core products and services include atmospheric and process gases such as oxygen, nitrogen and argon; hydrogen and helium; carbon dioxide; and a portfolio of higher?value specialty and electronic gases.